Insider · CIK 0002036798
Margaret A. Alexander
coopresidentofficer
Files at OVID (Ovid Therapeutics Inc.). First filing Jan 29, 2025, latest Feb 28, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 1
$4,971 bought, $2,956 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OVID: Ovid Therapeutics Inc.
OVIDOct 9, 2026 · close 2.46
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | OVIDsell Ovid Therapeutics Inc. | $2,956 5,279 shares | -7% | - | |
| 26Weak | OVIDbuy Ovid Therapeutics Inc. | $4,971 6,810 shares | +24% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | OVID Ovid Therapeutics Inc. | SOpen-market sale Common Stock | -5,279 | $0.56 | $2,956 | 73,406 | Feb 28, 2025 |
| Feb 20, 2025 | OVID Ovid Therapeutics Inc. | AGrant or award Common Stock | +43,750 | $0.00 | $0 | 78,685 | Feb 24, 2025 |
| Feb 20, 2025 | OVID Ovid Therapeutics Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +262,500 | $0.00 | $0 | 262,500 | Feb 24, 2025 |
| Jan 27, 2025 | OVID Ovid Therapeutics Inc. | POpen-market purchase Common Stock | +6,810 | $0.73 | $4,971 | 34,935 | Jan 29, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.